Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.4.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.46.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDFEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.575.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.620EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDMEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.6.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XPEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used